ConductScience.org, home

Paper36927491

Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.

Gonzalez-Ortiz F and 5 others. Mol Neurodegener, 2023. Cited by 189 papers, by iCite.

Cite this record

ConductScience Library. Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications. Papers, record 36927491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36927491

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.
PubMed
Journal
Mol Neurodegener
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
189
iCite
Relative citation ratio, by iCite
22.8
iCite
Revised in PubMed
2023-03-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gonzalez-Ortiz FFernando
2Kac PRPrzemysław R
3Brum WSWagner S
4Zetterberg HHenrik
5Blennow KKaj
6Karikari TKThomas Khttps://orcid.org/0000-0003-1422-4358

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Cognitive DysfunctionMajor topic
Humans
tau Proteins
Biomarkers
Neuropathology
Amyloid beta-Peptides

Source PubMed

Download CSV of topics

References99

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135618838Performance of plasma phosphorylated tau 181 and 217 in the community.Nat Med2022https://conductscience.org/library/papers/35618838PubMed
236251300Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial.JAMA Neurol2022https://conductscience.org/library/papers/36251300PubMed
334998485Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.Lancet Public Health2022https://conductscience.org/library/papers/34998485PubMed
423399646Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood.Nat Rev Neurol2013https://conductscience.org/library/papers/23399646PubMed
536456833Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring.Nat Med2022https://conductscience.org/library/papers/36456833PubMed
627371494A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.Neurology2016https://conductscience.org/library/papers/27371494PubMed
728592453Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.Neurology2017https://conductscience.org/library/papers/28592453PubMed
833585983Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.Acta Neuropathol2021https://conductscience.org/library/papers/33585983PubMed
929653606NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement2018https://conductscience.org/library/papers/29653606PubMed
1032725127Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease.J Exp Med2020https://conductscience.org/library/papers/32725127PubMed
1134494715Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.Alzheimers Dement2022https://conductscience.org/library/papers/34494715PubMed
1233252199Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.Alzheimers Dement2021https://conductscience.org/library/papers/33252199PubMed
1316488378Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.Lancet Neurol2006https://conductscience.org/library/papers/16488378PubMed
1427068280CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.Lancet Neurol2016https://conductscience.org/library/papers/27068280PubMed
1522487856Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.J Neuropathol Exp Neurol2012https://conductscience.org/library/papers/22487856PubMed
161759558Neuropathological stageing of Alzheimer-related changes.Acta Neuropathol1991https://conductscience.org/library/papers/1759558PubMed
1732722745Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.JAMA2020https://conductscience.org/library/papers/32722745PubMed
1824231570Cerebrospinal fluid biomarkers in cardiac arrest survivors.Resuscitation2014https://conductscience.org/library/papers/24231570PubMed
1933283854CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.Brain2021https://conductscience.org/library/papers/33283854PubMed
2031129184Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid.Clin Biochem2019https://conductscience.org/library/papers/31129184PubMed

See all 99 referencesDownload CSV of references

Cited by145

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.

PMIDTitleJournalYearIn PapersSource
42948835Blood-Based Biomarkers in Alzheimer's Disease: Advances in Detection Technologies and Clinical Applications.Aging Med (Milton)2026https://conductscience.org/library/papers/42948835PubMed
42926809Plasma eMTBR-tau as a robust biomarker for Alzheimer's disease tangle pathology up to 10 years before death.medRxiv2026https://conductscience.org/library/papers/42926809PubMed
42795418
Comparative Analysis of Plasma Biomarkers of Alzheimer's Disease and Frontotemporal Dementia: The Dual Role of Soluble Fractalkine as a Biomarker of Frontotemporal Dementia and Its Neuroprotective Effects in Cortical Neurons "In Vitro".
Life (Basel)2026https://conductscience.org/library/papers/42795418PubMed
42670516Circulating pTau181 and Genomic Background in Dogs: A Pilot Study on Neurobiological Aging.Vet Med Int2026https://conductscience.org/library/papers/42670516PubMed
42631717Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis.Eur Arch Psychiatry Clin Neurosci2026https://conductscience.org/library/papers/42631717PubMed
42585316Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers.Sci Adv2026https://conductscience.org/library/papers/42585316PubMed
42463545Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers.EMBO Mol Med2026https://conductscience.org/library/papers/42463545PubMed
42437975Proteomics of post mortem brains in early- and late-onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers.Alzheimers Dement2026https://conductscience.org/library/papers/42437975PubMed
42422561Brain age gradients as intermediate phenotypes linking plasma p-tau217 to cognition in community-dwelling older adults.NPJ Dement2026https://conductscience.org/library/papers/42422561PubMed
42415930Peripheral metabolomic profiling reveals lipid and amino acid alterations associated with immuno-inflammatory responses in treatment-naïve late-onset Alzheimer's disease.Front Aging Neurosci2026https://conductscience.org/library/papers/42415930PubMed
42396306Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer's Disease Psychosis: Evidence from Two Cohorts.medRxiv2026https://conductscience.org/library/papers/42396306PubMed
42368190Atypical involvement of Alzheimer's tau proteins in diseases beyond tauopathies.Life Med2026https://conductscience.org/library/papers/42368190PubMed
42340485Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.Acta Neuropathol2026https://conductscience.org/library/papers/42340485PubMed
42325435The gut-brain axis in Alzheimer's disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities.Front Mol Biosci2026https://conductscience.org/library/papers/42325435PubMed
42273887Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort.Alzheimers Dement2026https://conductscience.org/library/papers/42273887PubMed
42251493Age-related increase in plasma p-tau217 in amyloid-beta-negative cognitively unimpaired individuals affects diagnostic interpretation.Alzheimers Dement2026https://conductscience.org/library/papers/42251493PubMed
42238423CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progression.medRxiv2026https://conductscience.org/library/papers/42238423PubMed
42171824β-Asarone, Tenuifolin, and YuanZhi Decoction Restore Cognitive Function and Modulate GRIN2B-Associated Autophagy in Alzheimer's Disease.Neurochem Res2026https://conductscience.org/library/papers/42171824PubMed
42164127Integrating neuroimaging and plasma biomarkers to predict preclinical Alzheimer's disease progression.Front Neurol2026https://conductscience.org/library/papers/42164127PubMed
42004319Heme-mediated Tau phosphorylation drives neurocognitive responses in sickle cell disease.Blood Red Cells Iron2026https://conductscience.org/library/papers/42004319PubMed

See all 145 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36927491

GET https://conductscience.org/api/papers/v1/36927491/references?page=2